摘要
目的:观察阿奇霉素联合泼尼松对肺炎支原体感染后咳嗽变异性哮喘的疗效。方法:将78例肺炎支原体感染后诱发的咳嗽变异性哮喘患者随机分为两组,分别予以单用阿奇霉素(对照组36例)和加用泼尼松联合口服治疗(治疗组42例)并进行比较。结果:治疗组显效35例(83.3%),对照组显效21例(58.3%),治疗组优于对照组(χ2=5.98,P<0.05)。治疗组不良反应6例,对照组8例,两组比较差异无统计学意义(χ2=0.83,P>0.05)。结论:阿奇霉素联合泼尼松能明显提高治疗肺炎支原体感染诱发咳嗽变异性哮喘的效果。
Objective： To observe the effect of Azithromycin combined with Prednisone for cough variant asthma that induced by mycoplasma pneumoniae infection.Methods：78 cases with cough variant asthma, which induced by mycoplasma pneumoniae infection, were randomly divided into 2 groups. The treatment group was treated with Azithromycin combined with Prednisan, and contrast group with Azithromycin only. The results be- tween both groups were compared. Conclustion： It could increase the effect on patients with Cough variant asthma that induced by mycoplasma pneumoni- ae infection used Azithromycin combined with Prednisone.
出处
《中国民康医学》
2010年第8期924-924,976,共2页
Medical Journal of Chinese People’s Health
关键词
阿奇霉素
肺炎支原体
咳嗽变异性
Azithromycin
Prednisone
Mycoplasma pneumoniae
Cough variant
